Baiyunshan Rabies Vaccine Receives Macau Drug Registration Certificate

Regulation
โดย Jiemian·CNMO·Read original
Summary · why it matters

Baiyunshan announced that Baiyunshan Bio, which is within its consolidated reporting scope, has received a Certificate of Drug Registration for its freeze-dried human rabies vaccine, Vero cells, issued by the Pharmaceutical Administration Bureau of the Macau Special Administrative Region Government. The vaccine will be authorized for sale in Macau by GPHL International Macau. Previously, the product obtained a Drug Registration Certificate from the National Medical Products Administration in December 2025, with cumulative R&D investment of approximately 205 million yuan.

Impact on stocks 1

Others▲ · 1 stocks

Off-coverage companies 1

广药国际（澳门）Private▲ Positive
Regulationrelevance

GPHL International Macau is named as the entity authorized to sell the newly registered rabies vaccine in Macau.

© 2026 MarketDXNews